Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2024-05-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$160.7m reported value +33.1% vs Q4 2023
34positions
76.3%in top 10
5 new 5 added 1 reduced 3 sold out vs Q4 2023

Holdings, Q1 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APPLIED THERAPEUTICS INC COM APLT APLT 5,574,687 $37.9m23.58% 23.58% AddedShares held: Q2 2023 3.5m, Q3 2023 5.2m, Q4 2023 5.5m, Q1 2024 5.6m +100.0k +100,000 1.8%
2 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 490,422 $26.8m16.69% 16.69% UnchangedShares held: Q2 2023 450.4k, Q3 2023 490.4k, Q4 2023 490.4k, Q1 2024 490.4k
3 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 5,475,516 $17.9m11.14% 11.14% UnchangedShares held: Q2 2023 3.0m, Q3 2023 3.0m, Q4 2023 5.5m, Q1 2024 5.5m
4 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 600,000 $10.1m6.30% 6.30% UnchangedShares held: Q2 2023 500.0k, Q3 2023 600.0k, Q4 2023 600.0k, Q1 2024 600.0k
5 SPDR GOLD TR GOLD SHS GLD GLD 32,000 $6.6m4.10% 4.10% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 32.0k
6 ENTERA BIO LTD SHS ENTX ENTX 3,881,879 $6.5m4.03% 4.03% UnchangedShares held: Q2 2023 2.5m, Q3 2023 2.5m, Q4 2023 3.9m, Q1 2024 3.9m
7 ALTIMMUNE INC COM NEW ALT ALT 567,219 $5.8m3.59% 3.59% AddedShares held: Q2 2023 173.9k, Q3 2023 0, Q4 2023 200.0k, Q1 2024 567.2k +367.2k +367,219 183.6%
8 HOOKIPA PHARMA INC COM COM 5,517,385 $3.9m2.44% 2.44% UnchangedShares held: Q2 2023 5.5m, Q3 2023 5.5m, Q4 2023 5.5m, Q1 2024 5.5m
9 SEABRIDGE GOLD INC COM COM 246,597 $3.7m2.32% 2.32% UnchangedShares held: Q2 2023 80.0k, Q3 2023 246.6k, Q4 2023 246.6k, Q1 2024 246.6k
10 EQUINOX GOLD CORP COM EQX EQX 550,811 $3.3m2.06% 2.06% AddedShares held: Q2 2023 0, Q3 2023 420.9k, Q4 2023 420.9k, Q1 2024 550.8k +129.9k +129,882 30.9%
11 AGNICO EAGLE MINES LTD COM AEM AEM 55,500 $3.3m2.06% 2.06% UnchangedShares held: Q2 2023 0, Q3 2023 40.0k, Q4 2023 55.5k, Q1 2024 55.5k
12 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 200,000 $3.2m2.00% 2.00% UnchangedShares held: Q2 2023 200.0k, Q3 2023 200.0k, Q4 2023 200.0k, Q1 2024 200.0k
13 SILVERCREST METALS INC COM SIL SIL 470,000 $3.1m1.95% 1.95% UnchangedShares held: Q2 2023 170.0k, Q3 2023 410.0k, Q4 2023 470.0k, Q1 2024 470.0k
14 FRANCO NEV CORP COM FNV FNV 25,000 $3.0m1.85% 1.85% NewShares held: Q2 2023 7.0k, Q3 2023 14.5k, Q4 2023 0, Q1 2024 25.0k
15 MAG SILVER CORP COM MAG MAG 275,000 $2.9m1.81% 1.81% AddedShares held: Q2 2023 0, Q3 2023 160.0k, Q4 2023 105.0k, Q1 2024 275.0k +170.0k +170,000 161.9%
16 WHEATON PRECIOUS METALS CORP COM WPM WPM 60,000 $2.8m1.76% 1.76% UnchangedShares held: Q2 2023 0, Q3 2023 47.5k, Q4 2023 60.0k, Q1 2024 60.0k
17 KINROSS GOLD CORP COM KGC KGC 440,000 $2.7m1.68% 1.68% UnchangedShares held: Q2 2023 0, Q3 2023 440.0k, Q4 2023 440.0k, Q1 2024 440.0k
18 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $1.9m1.20% 1.20% UnchangedShares held: Q2 2023 13.0k, Q3 2023 13.0k, Q4 2023 13.0k, Q1 2024 13.0k
19 OCULAR THERAPEUTIX INC COM OCUL OCUL 200,400 $1.8m1.13% 1.13% UnchangedShares held: Q2 2023 200.0k, Q3 2023 400, Q4 2023 200.4k, Q1 2024 200.4k
20 VISA INC COM CL A V V 4,850 $1.4m0.84% 0.84% UnchangedShares held: Q2 2023 4.8k, Q3 2023 4.8k, Q4 2023 4.8k, Q1 2024 4.8k
21 GLOBAL X FDS GLOBAL X SILVER SIL SIL 45,175 $1.2m0.77% 0.77% ReducedShares held: Q2 2023 89.7k, Q3 2023 89.7k, Q4 2023 176.0k, Q1 2024 45.2k -130.8k -130,825 -74.3%
22 ALAMOS GOLD INC NEW COM CL A AGI AGI 80,000 $1.2m0.73% 0.73% UnchangedShares held: Q2 2023 0, Q3 2023 80.0k, Q4 2023 80.0k, Q1 2024 80.0k
23 CVS HEALTH CORP COM CVS CVS 14,500 $1.2m0.72% 0.72% UnchangedShares held: Q2 2023 14.5k, Q3 2023 14.5k, Q4 2023 14.5k, Q1 2024 14.5k
24 ISHARES SILVER TR ISHARES SLV SLV 48,500 $1.1m0.69% 0.69% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 48.5k
25 NORTHROP GRUMMAN CORP COM NOC NOC 2,165 $1.0m0.64% 0.64% UnchangedShares held: Q2 2023 2.2k, Q3 2023 2.2k, Q4 2023 2.2k, Q1 2024 2.2k
26 ISHARES TR US AER DEF ETF ITA ITA 7,650 $1.0m0.63% 0.63% UnchangedShares held: Q2 2023 0, Q3 2023 0, Q4 2023 7.7k, Q1 2024 7.7k
27 DIAGEO PLC SPON ADR NEW DEO DEO 6,750 $1.0m0.62% 0.62% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 6.8k
28 ROYAL GOLD INC COM RGLD RGLD 7,550 $919.7k0.57% 0.57% UnchangedShares held: Q2 2023 0, Q3 2023 7.5k, Q4 2023 7.5k, Q1 2024 7.5k
29 PHILIP MORRIS INTL INC COM PM PM 10,000 $916.2k0.57% 0.57% UnchangedShares held: Q2 2023 0, Q3 2023 0, Q4 2023 10.0k, Q1 2024 10.0k
30 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 260,470 $859.6k0.53% 0.53% AddedShares held: Q2 2023 0, Q3 2023 0, Q4 2023 160.5k, Q1 2024 260.5k +100.0k +100,000 62.3%
31 NEW PAC METALS CORP COM NEWP NEWP 485,000 $649.9k0.40% 0.40% UnchangedShares held: Q2 2023 0, Q3 2023 131.7k, Q4 2023 485.0k, Q1 2024 485.0k
32 Orgenesis, Inc. COM COM 634,738 $521.8k0.32% 0.32% UnchangedShares held: Q2 2023 634.7k, Q3 2023 634.7k, Q4 2023 634.7k, Q1 2024 634.7k
33 OPUS GENETICS INC COM IRD IRD 100,000 $201.0k0.13% 0.13% UnchangedShares held: Q2 2023 100.0k, Q3 2023 100.0k, Q4 2023 100.0k, Q1 2024 100.0k
34 SKEENA RES LTD NEW COM SKE SKE 38,786 $179.2k0.11% 0.11% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 38.8k

Sold out since Q4 2023

SecurityTickerShares held beforeValue then
VANECK ETF TRUST GDX GDX 91,850 $2.8m91.8k shares
VANECK ETF TRUST GDXJ GDXJ 53,150 $2.0m53.1k shares
THERMO FISHER SCIENTIFIC INC TMO TMO 2,100 $1.1m2.1k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08